SEATTLE GENETICS $36.70

up +0.38


17/5/2013 04:17 PM  |  NASDAQ : SGEN  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 80% - SGEN has outperformed the S&P 500 by 54%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Seattle Genetics Commences Two Phase I Trials of SGN-CD19A

    Benzinga

  2. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall ...

    GuruFocus

  3. Seattle Genetics and Millennium Initiate Global Phase III Clinical ...

    Benzinga

  4. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall ...

    GuruFocus

  5. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 50,983 Shares

    GuruFocus

  6. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus

  7. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus

  8. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus

  9. Seattle Genetics Offers Data on Next-Gen Antibody-Drug Conjugate ...

    Benzinga

  10. Seattle Genetics Presents Encouraging ADCETRIS Data in ...

    Benzinga

  11. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall ...

    GuruFocus

  12. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 27,327 Shares

    GuruFocus

  13. Seattle Genetics Falls After Q3 Results and Analyst Downgrade

    Benzinga

  14. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall ...

    GuruFocus

  15. Millennium, Seattle Genetics Announce Phase 3 Clinical Trial of ...

    Benzinga

  16. Seattle Genetics Announces EC Conditional Marketing Authorization ...

    Benzinga

  17. Seattle Genetics Will Get Undisclosed Milestone Payments

    Benzinga

  18. Schaeffer's Quantitative Analyst eyes three stocks with contrarian ...

    By SchaeffersResearch

  19. Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN

    GuruFocus

  20. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall ...

    GuruFocus

  21. WEEKLY CFO SELLS HIGHLIGHT: SBAC, XOXO, MTH, FICO, SGEN, OAS

    GuruFocus

  22. Seattle Genetics Inc. (SGEN) CFO Todd E Simpson sells 40,000 Shares

    GuruFocus

  23. Health Care Sector Wrap

    FOXBusiness

  24. Exelixis, Universal Display Corporation Among Stocks Up on High ...

    FOXBusiness

  25. Seattle Genetics Inc. Reports Operating Results (10-Q)

    GuruFocus

  26. Seattle Genetics

    Investors Business Daily

  27. Seattle Genetics Inc. (SGEN) President and CEO Clay B Siegall ...

    GuruFocus

  28. Seattle Genetics Announces ADCETRIS Receives Positive CHMP Opinion ...

    Benzinga

  29. Health Care Sector Wrap

    FOXBusiness

  30. Seattle Genetics Inc. (SGEN) President & CEO Clay B Siegall sells ...

    GuruFocus

  31. Benzinga's Top Initiations

    Benzinga

  32. UPDATE: Piper Jaffray Downgrades Seattle Genetics to Underweight ...

    Benzinga

  33. Seattle Genetics Hit with Heavy Put Volume

    By SchaeffersResearch

  34. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 25,000 Shares

    GuruFocus

  35. Seattle Genetics (SGEN) Slips 1.8% After Big Gains Last Week

    At Market Intelligence Center

  36. Weekly CFO Sells Highlight: SWKS, P, SGEN, RT

    GuruFocus

  37. Seattle Genetics Inc. (SGEN) CFO Todd E Simpson sells 35,000 Shares

    GuruFocus

  38. Front-month traders prefer out-of-the-money call options on SGEN

    By SchaeffersResearch

  39. Seattle Genetics Announces Data from Investigator Trial of ...

    Benzinga

  40. Seattle Genetics (SGEN) Down 3.5% on Revenue Miss

    At Market Intelligence Center

  41. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 4,000 Shares

    GuruFocus

  42. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 46,000 Shares

    at GuruFocus

  43. Seattle Genetics Inc. Reports Operating Results (10-K)

    at GuruFocus

  44. 5 Resilient Biotech Stocks to Buy for 2012

    at GuruFocus

  45. Seattle Genetics (SGEN) Loses 5.3% After Failing To Provide ...

    At Market Intelligence Center

  46. Notable Put Options Activity in Seattle Genetics

    at Benzinga

  47. Benzinga's M&A Chatter for Thursday January 26, 2012

    at Benzinga

  48. Oppenheimer Reiterates Outperform, $26 PT On Seattle Genetics

    at Benzinga

  49. Seattle Genetics Announces Updates to ADCETRIS Prescribing Information

    at Benzinga

  50. Seattle Genetics Inc. (SGEN) President and CEO Clay B Siegall ...

    at GuruFocus

  51. Best Biotech Stocks of 2011

    at Benzinga

  52. Benzinga's M&A Chatter for Thursday December 15, 2011

    at Benzinga

  53. Seattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS ...

    at Benzinga

  54. Why Biotech Investors Must Understand the FDA's Adverse Events Reports

    at Benzinga

  55. Bears Converge on Seattle Genetics, Despite Positive Price Action

    By SchaeffersResearch
People viewing SGEN also viewed: , , , , , ,
Marketplace
Trading Center